Q2 FY25 Press.pdf (506.0 KB)
Result is flat …wait and watch of management commentary
Q2 FY25 Press.pdf (506.0 KB)
Result is flat …wait and watch of management commentary
Yup, Khorakiwala mentioned in one of interview, look for it.
Was this mentioned in the last investor meet? There has been increased interest since last week.
Also, what are some of the risks currently? Their FDA trials (phase 3) have been successful so far, and 90% complete. Once the trials get completed, what would be the expected timeline for revenue to start hitting company books?
It is really a huge figure… Did he really quoted this figure?? Please submit the source if you are having…
Another tepid results as expected. Will keep on reporting higher losses as they onboard more employees and as AUM will come with lag… Employees as of Sep – 70 (March24 – 51)
In a recent interview MD mentioned launch of PMS biz this quarter. Another takeaway was employees of Shriram Finance are undergoing certification and training (for group distribution). Link below
Interview with Mr. Kartik Jain, MD & CEO, Shriram Asset Management Company
Have added back 25% qnty which was sold earlier as the financialization theme is hitting all time highs be it UTI/Nippon/HDFC AMC, BSE/MCX, Nuvama/Anand Rathi Wealth Management and distributors…
CIE Automotive India Limited, formerly known as Mahindra CIE Automotive Limited, is a subsidiary of CIE Automotive S.A., headquartered in Spain. The company operates as a full-service supplier of automotive components and sub-assemblies, managing high-value-added processes sustainably and efficiently. With a strong global presence, CIE Automotive is recognized for its technological expertise and established relationships with original equipment manufacturers (OEMs).
CIE Automotive India Limited is characterized by its multi-locational and multi-technology approach to manufacturing automotive components. The company operates manufacturing facilities and engineering capabilities in various countries, including India, Germany, Spain, Lithuania, Italy, and Mexico. This diverse operational footprint allows it to cater to a wide range of automotive segments.
CIE India specializes in producing complex automotive parts that include:
The company operates across six primary business segments:
These segments serve various automotive markets, including passenger vehicles (PVs), commercial vehicles (CVs), tractors, two-wheelers (2Ws), and off-highway vehicles.
Following its acquisition of Aurangabad Electricals Limited in 2019, CIE India expanded its manufacturing capabilities to 31 facilities, with eight located in Europe. This extensive network supports its production of high-value components.
CIE India supplies major automotive OEMs and Tier 1 suppliers such as:
As of April 2022:
CIE Automotive is investing heavily in expanding its capacity across various divisions in India:
The company remains open to mergers and acquisitions to further bolster its growth strategy.
CIE Automotive India Limited has identified several key areas for potential revenue growth:
Capitalising on India’s Automotive Market Growth:
Leveraging Global Expertise:
Strategic Focus on High-Growth Segments:
Improving Operational Efficiency:
Exploring Inorganic Growth Opportunities:
While the outlook for CIE Automotive India Limited appears positive, several challenges must be addressed:
There is a 99% chance of new drug approval now, launch in Feb 2025, as oer MD market is 80 B USD which is huge, lot of growth in intrinsic value going forward, WCK4777 is also fast tracked, Wockhardt has three more molecules in QIDP, this might become most valuable company of Pharma sector based on opportunity size. First indian company to launch a drug.
Disclaimer: holding from 600 levels in core portfolio for long long term.
At the moment it seems that the distributors are trying to offload inventory and we can see that from the data of increased inventory and higher discounts.
I would wait and watch at the moment as I expect some patchiness in the auto ancillary sector given that it is a laggard to the actual automobile sales.
Would be interesting to get more inputs on this.
Final Anti-dumping duty rate for the period 2022-23 is 0%.
Column 1 | Column 2 | Column 3 | Column 4 | E | F | G |
---|---|---|---|---|---|---|
CHANNEL REVENUE SPLIT | Q2fy25 | Q1y25 | Q4fy24 | Q3fy24 | Q2fy24 | Q1fy24 |
Multi Brand Outlets | 5211 | 5757 | 5931 | 5679 | 5668 | 5615 |
Large Format Stores | 362 | 357 | 349 | 357 | 334 | 318 |
Defence canteens | 440 | 320 | 430 | 430 | 430 | 430 |
Retail | 46 | 47 | 39 | 38 | 29 | 29 |
Luxury Retail | 137 | 147 | 128 | 120 | 106 | 103 |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!